The Commission concurs with the opinions of the Agency and therefore considers it appropriate to amend the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ to introduce the administrative and minor changes requested by Lanxess Deutschland GmbH.
Recital 8, Regulation (EU) 2026/2024
In forcesince 10 Sep 2026